The results demonstrated that knockdown of ESRRG downregulated PCNA, MMP-2, VIMENTIN, and N-cadherin, while upregulating E-cadherin expression, suggesting that ESRRG may promote tumor migration and invasion by modulating EMT. The gene discussed is CDH1; the disease is neoplasm.